( S ( NP-SBJ ( DT The ) ( NNP FDA ) ) ( VP ( VBZ has ) ( VP ( VBD said ) ( SBAR ( S ( NP-SBJ ( PRP it ) ) ( VP ( VBD presented ) ( NP ( NP ( NN evidence ) ) ( SBAR ( S ( NP-SBJ ( PRP it ) ) ( VP ( VBD uncovered ) ) ) ) ) ( PP ( TO to ) ( NP ( DT the ) ( NN company ) ) ) ( VP-2 ( VBG indicating ) ( SBAR ( IN that ) ( S ( NP-SBJ-3 ( NNP Bolar ) ) ( VP ( VBD substituted ) ( NP ( DT the ) ( JJ brand-name ) ( NN product ) ) ( PP-CLR ( IN for ) ( NP ( PRP$ its ) ( JJ own ) ) ) ( S-PRP ( VP ( TO to ) ( VP ( VB gain ) ( NP ( NN government ) ( NN approval ) ( S ( VP ( TO to ) ( VP ( VB sell ) ( NP ( NP ( JJ generic ) ( NNS versions ) ) ( PP ( IN of ) ( NP ( NNP Macrodantin ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) )